NCT06304896 - Colchicine Versus Beta-blockers, Angiotensin-converting Enzyme Inhibitors, and Statins for Prevention of Chemotherapy-Induced Cardiomyopathy | Biotech Hunter

Enrollment

150

Participants

Timeline

Start Date

May 1, 2024

Primary Completion Date

May 1, 2025

Study Completion Date

December 1, 2025

Conditions

Chemotherapy Induced Systolic Dysfunction

Interventions

DRUG

Carvedilol

Carvedilol 6.25 mg oral tablets. Prescribed: Twice daily PO with 200 mL of water.

DRUG

Ramipril

Ramipril 2.5 mg oral capsules. Prescribed: Once daily PO with 200 mL of water.

DRUG

Rosuvastatin

Rosuvastatin 20 mg oral tablets. Prescribed: Once daily PO with 200 mL of water.

DRUG

Colchicine

Colchicine 0.6 mg oral tablets/capsules. Prescribed: Once daily PO with 200 mL of water.

DRUG

Placebo

Placebo oral capsules. Prescribed: Once daily PO with 200 mL of water.

Trial Locations (1)

Arab Contractors Medical Centre, Cairo

All Listed Sponsors

lead

Arab Contractors Medical Centre

OTHER